or
forgot password

    • cancer clinical trials in santa fe, NM

    • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Breast Cancer
    Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
    Santa Fe Hematology/Oncology
    Santa Fe, New Mexico 87505
    Lung Cancer
    ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Prostate Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    New Mexico Cancer Care Associates

    Trial Locations
    New Mexico Cancer Care Associates
    Santa Fe Cancer Center at St. Vincent Hospital
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    St. Vincent Cancer Center at St. Vincent Regional Medical Center
    Santa Fe, New Mexico 87505
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    New Mexico Cancer Care Associates

    Trial Locations
    New Mexico Cancer Care Associates
    St. Vincent Regional Cancer Center
    Colorectal Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Pancreatic Cancer
    Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Rectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
    New Mexico Cancer Care, Cancer Institute of New Mexico

    Trial Locations
    New Mexico Cancer Care, Cancer Institute of New Mexico
    St. Vincent Regional Cancer Care Center
    Non-small Cell Lung Cancer
    Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Chronic Myeloid Leukemia
    Phase II Sunitinib Prog Met AIPC
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Metastatic Prostate Cancer
    Gemzar, Cisp, Sunitinib Urothelial Ca
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Urothelial Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Advanced Prostate Cancer, Prostatic Neoplasms
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Prostate Cancer
    A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Endometrial Neoplasms
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Breast Cancer
    Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Non-small Cell Lung Cancer
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Prostate Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Breast Cancer
    S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Breast Cancer
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Neoplasms, Diarrhea
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Breast Neoplasms, Breast Cancer, Metastasis
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    New Mexico Cancer Care
    Santa Fe, New Mexico 87505
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    New Mexico Cancer Center Associates
    Santa Fe, New Mexico 87501
    Non-Small Cell Lung Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Non Small Cell Lung Carcinoma
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Carcinoma, Non-Small-Cell Lung
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Colorectal Neoplasms
    A Multiple Myeloma Trial in Patients With Bone Metastases
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Multiple Myeloma
    Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Osteoporosis
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Osteoporosis
    A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Leukemia, Other, Cancer
    Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Liver, Cancer
    Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
    St. Vincent Regional Medical Center
    Santa Fe, New Mexico 87505
    Liver Cancer
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Carcinoma, Non-Small-Cell Lung
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    Boehringer Ingelheim Investigational Site
    Santa Fe, New Mexico
    HIV Infections
    Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
    New Mexico Cancer Care Associates

    Trial Locations
    New Mexico Cancer Care Associates
    St. Vincent Regional Medical Center
    Sarcoma
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Metastatic Breast Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
    New Mexico Cancer Care Associates

    Trial Locations
    New Mexico Cancer Care Associates
    St. Vincent Regional Medical Center
    Cancer
    Erlotinib Versus Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Carcinoma, Non-Small-Cell Lung